Sun Pharma's Q2 Profit Falls 36% Due to Exceptional Charges

• Sun Pharma's Q2 profit fell 36% year-on-year to Rs 1,989 crore.
• Exceptional charges related to US litigation and Organon acquisition affected earnings.
• Revenue from operations increased by 12% to Rs 16,199 crore.
• Specialty drug sales remained strong despite the profit decline.
• The company reported a 12% increase in revenue to Rs 16,199 crore.